Could a cheap hormone boost IVF success for women with low egg reserve?

NCT ID NCT07108621

Recruiting now Disease control Sponsor: Kristine Loessl Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study tests whether taking a low dose of the hormone hCG for 8 weeks before IVF can increase the number of eggs retrieved in women with diminished ovarian reserve. About 80 women will be randomly assigned to receive either hCG or a placebo. The main goal is to see if hCG leads to more eggs being collected during the IVF cycle.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: human chorionic gonadotropin (hCG)
What this could lead to: If it works, this could improve egg yield in IVF for women with low ovarian reserve, potentially increasing their chances of pregnancy.
What could go wrong: This is a small, early-phase trial with only 80 participants. The previous study showed promise, but results may not be confirmed or widely applicable.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for IN VITRO FERTILIZATION (IVF) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

female infertility

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

IN VITRO FERTILIZATION (IVF) INFERTILITY, FEMALE OVARIAN RESERVE

Contacts and locations

Locations

Fertility Clinic, Department of Gynaecology, Fertility and Obstetrics, Copenhagen University Hosital Rigshospitalet
RECRUITING

Copenhagen, 2100, Denmark

More trials for these conditions

Other studies related to the condition(s) this trial covers.